Faculty

Specialty: Endocrinology

Dr. Bee is the Head and Senior Consultant of the Department of Endocrinology at Singapore General Hospital (SGH) and holds the position of Clinical Associate Professor at Duke-NUS Medical School, Singapore. Dr. Bee graduated from the National University of Singapore and completed his specialist training in Endocrinology at SGH and research training at the Joslin Diabetes Centre in Boston, USA. His clinical focus is primarily on the management of diabetes mellitus and lipid disorders. Dr. Bee leads research programmes aimed at diabetes prevention, risk prediction for diabetic complications, and leveraging artificial intelligence in diabetes care. In addition to his roles at SGH and SingHealth, Dr. Bee is also the President of Diabetes Singapore.

Specialty: Endocrinology

Prof Manju Chandran is a Senior Consultant Endocrinologist and Director of the Osteoporosis and Bone Metabolism Unit at Singapore General Hospital, which she founded in 2007. She is also Clinical Professor at Duke-NUS Medical School and Chairperson of the Asia Pacific Consortium on Osteoporosis (APCO) leading bone health experts from 23 countries in the Asia Pacific. She spearheaded the development of the APCO Framework, the APCO Collective Intellect Clinical Case Discussion Platform (CICCDP), and multiple other educational tools to improve global osteoporosis care. She is the founder of WISHBONE, Singapore’s only osteoporosis support group, and leads multiple public education initiatives in Singapore.

Prof Chandran is board and Council of Scientific Advisors member of the IOF, Deputy Chair of its Asia Pacific Regional Advisory Council and Chair of the AP panel of the ISCD. She is an appointed member of the Bone Health Expert Group of the WHO and Steering Committee Member of the IOF Capture the Fracture Governance and the Global Rare Bone Disorders Summit.

She has won numerous accolades, including the 2025 ISCD Gluck Humanitarian Award, the 2023 ISCD Clinician of the Year Award and the 2021 IOF Olof Johnell Science Award. Her SGH-based fracture liaison service OPTIMAL was Asia Pacific’s first to earn IOF’s Gold Star.

With over 200 publications, her research spans osteoporosis, rare bone diseases, parathyroid disorders and diabetes-related bone issues. 

Specialty: Endocrinology and Diabetes

Dr. Khadija Hafidh has over 20 years of experience in Internal medicine, diabetes, obesity, metabolism and medical education. Currently, she heads the Diabetes Unit at Rashid Hospital, Dubai Academic Health Corporation.

She is a Fellow of the Royal College of Physicians of Edinburgh, and a member of the American College of Physicians.

She is a clinical Professor of Medicine at Mohammed Bin Rashid University College of Medicine, UAE.

She is a certified SCOPE obesity expert and Cardio-metabolic Health Specialist.

She is a member of the steering committee for the UAE National Diabetes Guidelines and Editorial Board Member of the Dubai Diabetes and Endocrine Journal

Her research interest include: cardiovascular complications in Diabetes and Obesity

Specialty: Endocrinology And Internal Medicine

Dr Gudmundur Johannsson is a Professor of Endocrinology and Vice Dean at the Sahlgrenska Academy, Faculty of Medicine, University of Gothenburg and a Senior Consultant at the Department of Endocrinology at Sahlgrenska University Hospital, Gothenburg, Sweden. He earned his medical degree from the University of Iceland, and training in internal medicine and clinical endocrinology at Sahlgrenska University Hospital. Professor Johannsson defended his thesis in 1997 and became a Senior Lecturer in 2003, progressed to Professor of Endocrinology in 2010, all at the Sahlgrenska Academy, University of Gothenburg. He was the head of Department of Endocrinology at the Sahlgrenska University Hospital in 2000 – 2011, Deputy Director of Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy in 2015-2018. He was also the Deputy Director Institute of Medicine, Sahlgrenska Academy between 2018-2023 and Vice Dean Sahlgrenska Academy, University of Gothenburg from 2024. Dr Johannsson was a Visiting Professor at the University of New South Wales, Sydney from 2001 to 2003. He is a Board member and past president of the Growth Hormone Research Society, board member of the Pituitary Society and member of the steering committee of European Reference Network on Rare Endocrine Conditions in the European Union.

Specialty: Endocrinology

Dr. Kong is Professor in the Department of Medicine and Therapeutics at The Chinese University of Hong Kong, and Honorary Consultant at the Prince of Wales Hospital, Hong Kong. Dr. Kong graduated from TheChinese University of Hong Kong and completed her training in General Medicine and Endocrinology at the Queen Elizabeth Hospital, Hong Kong. She had her overseas training as postdoctoral fellow under the mentorship of Dr. Robert Henry at the Division of Endocrinology, Department of Medicine at University of California, San Diego, United States between 1998 and 1999. She became a Fellow of the Hong Kong Academy of Medicine in 2000, with accreditation in Advanced Internal Medicine, Endocrinology, Diabetes and Metabolism. She is also a Fellow of the Royal College of Physicians, Glasgow, Edinburgh and London. She is the chairperson of Specialty Board in Advanced Internal Medicine, Hong Kong College of Physicians between 2017 and 2021. Dr. Kong’s research interests are obesity and diabetes with focuses on epidemiological studies and clinical trials related to lifestyle factors, technology and complications in adults and adolescents. Dr. Kong is the member of Nominating Committee for President, World Obesity Federation. She is a member of steering committees of multinational studies and advisory boards of Hong Kong Government and international agencies including the Global Advisory Group of World Obesity Day. She is the Editor in Chief of Primary Care Diabetes, Managing Editor of Obesity Reviews, Editorial Board Member of Diabetes Care, Section Editor of Current Diabetes Reports, and International Associate Editor of Diabetes Technology and Therapeutics. Dr. Kong is dedicated to teaching and won the Faculty Education Award in 2022. She has presented at numerous local, regional and international meetings and has published over 360 articles in international peer-reviewed journals.

Specialty: Endocrinology  

Dr Loh Wann Jia. Consultant – MBBS BSc (Hons) MRCP, M.Med, Clinical Assistant Professor Duke-NUS, Department of Endocrinology, Changi General Hospital, Singapore. Dr. Loh Wann Jia is a consultant endocrinologist working in Changi General Hospital. In 2019, she set up the Lipid Service in CGH and continues to build the lipid team. Apart from general endocrinology and internal medicine, she has subspecialty interest in metabolic conditions including obesity, dyslipidaemia, atypical diabetes, and severe insulin resistant states. She graduated from Imperial College London (U.K.) with Distinction and an intercalated degree of Bachelor of Science (BSc) in Endocrinology with 1st class honours. She has undertaken clinical and research fellowships in London (2017) and in Australia (HMDP 2022). She has written multiple publications related to dyslipidaemia, including Lp(a). She won a few research awards including Nurturing Clinician Researcher Award , Singhealth Publish! Award, and NMRC research training fund and NRMC population health-new investigator award.

A/Professor McCormack graduated in 2000 from the University of Sydney and undertook postgraduate training at the Royal North Shore Hospital. Her subsequent PhD examined the role of chemotherapy and genetic biomarkers in the management of aggressive pituitary tumours. In 2010 she completed a clinical and research fellowship in the Oxford Centre for Diabetes, Endocrinology and Metabolism, with a focus on pituitary tumours. She was then appointed to her current position as senior staff specialist in the Department of Endocrinology at St Vincent’s Hospital in 2011. She also heads The Hormones and Cancer Group at the Garvan Institute of Medical Research. Her primary research interests are in exploring the biology of aggressive pituitary tumours and investigating new treatment options, along with pituitary tumour genetics. As a member for the European Society of Endocrinology’s Taskforce on Aggressive Pituitary Tumours, she was integral to the development of guidelines on the management of aggressive pituitary tumours published in 2017. She is on the Board of the International Pituitary Society, heads the St Vincent’s Campus pituitary multidisciplinary team, is chair of the Sydney Pituitary Collaborative Group (SPCG) and co-chair of the Australia New Zealand Pituitary Alliance (ANZPA). She is current President of the Endocrine Society of Australia. She is also passionate about navigating change within the health system, promoting and supporting Women in Medicine and mentoring young clinicians.

Specialty: Pediatric Endocrinology (Bone And Mineral, Growth, And Skeletal Dysplasias)

Noriyuki Namba is a pediatric endocrinologist working at Tottori University Hospital. He received his MD and PhD from Okayama University and completed pediatric residency at Okayama University Hospital, followed by a research fellowship in bone cell biology at Washington University in St. Louis. After a pediatric endocrinology fellowship at Okayama University Hospital, he served as assistant/associate professor of pediatrics at Osaka University, acting as principal investigator in chondrocyte biology research. He then served as chief of pediatrics at Osaka Hospital as well as guest associate professor of pediatrics at Osaka University before joining Tottori University as full professor. His main interest is clinical/translational research concerning patients with disorders of bone and mineral metabolism. He chairs the Bone and Mineral Metabolism Committee of the Japanese Society for Pediatric Endocrinology (JSPE) as well as the Program Organizing Committee of the 12th International Meeting of Pediatric Endocrinology (IMPE 2027). 

Specialty: Internal Medicine

Thomas Pieber is Professor of Medicine, Chair of the Division of Endocrinology and Diabetology at the Department of Internal Medicine at Medical University of Graz in Austria. He is also Director of the Institute HEALTH – Institute for Biomedical Research and Technologies at Joanneum Research in Graz and founder and Chief Scientific Officer (CSO) of CBmed, a competence centre for biomarker research. His research includes diabetes, obesity and biomarker research in oncology and cardiovascular disease, including strategies for disease prevention and healthy aging. Thomas Pieber was and currently is lead principal investigator (PI) in several international study groups and multicenter trials funded by the EU Commission and foundations from USA. Professor Pieber has written more than 450 original papers and reviews in peer-reviewed journals. He is a member of the International Working Group on the Diabetic Foot and a member of the Cochrane Review Group “Endocrine and Metabolic Diseases”.

Specialty: Reproductive Endocrinology

Dr Richard Quinton is Consultant Endocrinologist in Newcastle-upon-Tyne since 1999, formerly with Newcastle-upon-Tyne Hospitals and currently with CNTW NHS Trust, and honorary Reader in Reproductive Endocrinology at Imperial College London. Graduating from Cambridge University in 1988, he trained in Internal Medicine at St Bart’s Hospital, London and at Erasmus University Hospital Rotterdam, followed by higher specialist training in Endocrinology at UCL Hospitals, London. He has been active in research for more than 30 years, with over 200 publications, principally relating to disorders of puberty and reproduction. In 2000, he was awarded the Ralph Noble Prize by Cambridge University and, in 2023, the Outstanding Clinical Practitioner award by the Society for Endocrinology (SfE). He is an associate editor of Clinical Endocrinology, Endocrine Connections and Reproduction & Fertility. He co-developed SfE guidelines groups on male (2022) and female (2024) hypogonadism, female hyperandrogenism (2025) and endocrine management of gender dysphoria (due in 2025).

Specialty: Endocrinology (Diabetes Medicine)

Solomon Tesfaye is a Consultant Physician/Endocrinologist at Sheffield Teaching Hospitals and Honorary Professor of Diabetic Medicine at the University of Sheffield. He is also Visiting Professor at Shanghai Jiao Tong University and Adjunct Professor at Xiangya Hospital Central Southern University, China.His research projects include the epidemiology, risk factors, pathogenesis, central nervous system involvement and treatment of diabetic neuropathy and neuropathic pain. He has published a book, over 200 original articles and reviews in diabetic neuropathy including a landmark study in the NEJM.Professor Tesfaye was awarded the Prestigious Camillo Golgi Prize of the European Diabetes Association in 2014 for major scientific contributions in Diabetic Neuropathy. He also received the Arnold Bloom Award of Diabetes UK in 2017 for innovative and patient-centered diabetes care; and the NHS Innovations National Award for One Stop Diabetes Screening Service in 2021. Prof Tesfaye served as Chair the International Expert Group on Diabetic Neuropathy 2010/11; and of NEURODIAB (2006-9) which is the largest diabetic neuropathy scientific group in the world. He is currently a member of the Diabetes UK Research Steering Group for diabetic complications. He is also an Associate Editor of Experimental Diabetes Research, Frontiers in Endocrinology, European Endocrinology and Diabetes Management and previously of Diabetologia and the Lancet Diabetes and Endocrinology. Professor Tesfaye also serves as grant review panel member for the JDRF, US NIH, Diabetes UK, UK NIHR, EFSD, MRC, Welcome Trust; and has been a member of 3 NICE guideline committees on neuropathic pain management and DPFS panel of the MRC. Finally, he has received several research grants including: 5 project grants from Diabetes UK, JDRF, NIH, EFSD, NIHR and a recent £2.97m UK HTA award to investigate the most effective treatment pathway for painful diabetic neuropathy.

Specialty: Endocrinology

Dr. Tham Kwang Wei is a Senior Consultant Endocrinologist in Woodlands Health, National Healthcare Group (NHG), Singapore. Prior to this, she was a Senior Consultant Endocrinologist at the Singapore General Hospital, where she spearheaded the establishment of an inter-disciplinary team in obesity management.  Her interest in the various aspects of obesity and its management has led to her research interests in these areas and to her involvement in pivotal consensuses, including the South and Southeast Asia Consensus on Obesity Care and Management and the recently published Lancet Commission on Clinical Obesity.  She is the current president of the Singapore Association for the Study of Obesity (SASO), a member of the Clinical Care Committee, World Obesity Federation (WOF) and the chair of the Integrated Health Committee, International Federation Society of Surgery for Obesity and Metabolic Disorders Asia Pacific Chapter (IFSO APC). 

Specialty: Endocrinology/Pituitary

Joseph G Verbalis, MD, graduated from Princeton University with an AB in 1971, and from the University of Pittsburgh with an MD in 1975. He completed residency training at the Hospital of the University of Pennsylvania from 1975-1978, and fellowship training in at the University of Pittsburgh from 1978-1980. He was a faculty member at the University of Pittsburgh from 1980-1995, then relocated to Georgetown University in Washington, DC, where he has served as Chief of the Division of Endocrinology and Metabolism since 1995. Dr. Verbalis’ research has been funded by the NIH for 40 years, and has focused on the physiology and pathophysiology of vasopressin and oxytocin. He has published over 300 journal articles, reviews, and book chapters related to vasopressin and oxytocin, and disorders of water homeostasis. He authors chapters on water metabolism in major textbooks of endocrinology, nephrology, and neuroscience. He is a regular speaker at meetings, with invited lectureships in 35 states and 37 countries.

Specialty: Endocrinology

Dr Yang obtained her medical degree from the National University of Singapore and received her Endocrinology training at the National University Hospital, Singapore, followed by a thyroid cancer fellowship at Memorial Sloan Kettering Cancer Centre, New York, where she was involved in clinical research in thyroid cancer. Through the pursuit of translational research, she aims to utilize personalized medicine in the clinical care of patients with cytologically-indeterminate thyroid nodules and RAI-refractory thyroid cancers. She has recently published her work on the validation of ThyroSeq performance in Singapore and also showed that the molecular test was a stronger predictor of malignancy than clinical parameters. She is studying regulatory mechanisms of sodium-iodide symporter in thyroid cancers with the aim of using therapeutics to optimize RAI uptake. She is the principal investigator for a re-differentiation therapy clinical trial in RAI-refractory metastatic thyroid cancer patients.

Specialty: Endocrinology (Endocrine Hypertension)

A/Professor Jun Yang is the Head of the Endocrine Hypertension Group at Hudson Institute of Medical Research, a Consultant Endocrinologist at Monash Health, and a Senior Researcher in the Department of Medicine at Monash University, Victoria, Australia. Jun graduated from Monash University with a MBBS (Hon) in 2001, attained her FRACP in 2010, and completed a PhD in 2013 focusing on tissue-selective coregulators of the mineralocorticoid receptor (MR). She has since advanced basic and clinical research in the field of MR-driven cardiovascular disease, particularly primary aldosteronism, contributing to 127 original publications. In 2016, she established Victoria’s first Endocrine Hypertension Service, fostering national and international collaborations to enhance the detection and management of primary aldosteronism and drive better patient outcomes.

Kevin Yuen, MD, is a neuroendocrinologist, medical director of both the Barrow Pituitary Center, and and the Barrow Neuroendocrinology Clinic, and is a professor in the Department of Neurology at Barrow Neurological Institute. He is board certified in both internal medicine and in endocrinology, diabetes, and metabolism by the American Board of Internal Medicine. Dr. Yuen’s expertise includes the diagnosis and treatment of pituitary and adrenal tumors and pituitary dysfunction, with a particular interest in growth hormone deficiency and excess, hypogonadism, and cortisol deficiency and excess. Dr. Yuen is also interested in neuroendocrine disorders in young adult cancer survivors and adults with traumatic brain injury. He is a fellow of the American College of Endocrinology. Dr. Yuen earned his medical degree from the University of Sheffield. He completed his residency in internal medicine at the University of Southampton and a fellowship in internal medicine, diabetes, and endocrinology at the University of Cambridge. Dr. Yuen is nationally and internationally known in the field of pituitary research, particularly for his work in growth hormone studies.

Specialty: Hypertension, Coronary artery disease, Treatment target, Cardiology.

Dr. Abdul Rashid Abdul Rahman is from Consultant Cardiovascular Physician and Visiting Professor, An Nur Specialist Hospital, Internal Medicine, Medan Pusat Bandar, Bandar Baru Bangi, Kajang, Selangor, located in Malaysia. His study is about Treatment of Hypertension in Patients with Coronary Artery Disease. He is also specialized in Hypertension, Coronary artery disease, Treatment target, Cardiology.

Currently the Consultant Paediatrician and Paediatric Endocrinologist in University Malaya Medical Centre and lecturer in University of Malaya. Graduated from University Malaysia Sarawak in 2001. Attained RCPCH, UK paediatrician certification in 2012. Completed subspecialty training in 2022 and did the fellowship training in Singapore KK Women and Children’s Hospital in 2021. Paediatric Endocrinologist at Hospital Putrajaya in 2022, and Hospital Tengku Ampuan Rahimah, Klang in 2023. Did a few studies and publications on the use of Growth hormone treatment, bisphosphonates, and early puberty in children during the fellowship.

Associate Professor Dr. Azriyanti Anuar Zaini holds the position of Consultant Paediatric Endocrinologist and Senior Lecturer in the Department of Paediatric, Faculty of Medicine, University of Malaya. She continues to contribute to the field through her clinical practice, research, and training of future pediatric endocrinologists. Dr Azriyanti completed her training and fellowship in paediatric endocrine (Malaysia & Oxford) and became a full-time consultant since 2015.

Dr. Azriyanti's contributions extend beyond her clinical work. She has authored several books and published numerous scientific articles in reputable journals, addressing various aspects of pediatric endocrinology, such as diabetes, thyroid disorders, and growth disorders. Her insights and contributions have helped shape the field of paediatric endocrinology and improve patient care.

Dr Foo Siew Hui is the Head of Endocrine Unit at Selayang Hospital. She is also practicing as a visiting Consultant Endocrinologist at Subang Jaya Medical Centre. Dr Foo completed her basic medical degree in 1999 with Bachelor of Medicine & Surgery (MBBS, 1st class honors) at University of Sydney, Australia followed by MRCP from United Kingdom in 2004. She obtained the Fellowship in Endocrinology in 2009 and started the endocrine service at Selayang Hospital in 2010. She is currently the Honorary Treasurer of the Malaysian Endocrine & Metabolic Society. She also serves as a trainer for the Ministry of Health Endocrinology Subspecialty Fellowship training and member of the task force for various national guidelines in diabetes and thyroid disorders. She is committed in continuous medical education by being involved actively in numerous workshops, seminars, conferences, forums and public health campaign at the state, national and regional level.

Dr Janet Hong Yeow Hua is a Consultant Paediatrician and Paediatric Endocrinologist, and Head of General Paediatric Department and Paediatric Endocrine Unit in Hospital Putrajaya. At national level, Dr Janet is the Head of Paediatric Endocrine Subspecialty services in Ministry of health Malaysia. She is an Elected Member of the Ministry of Health Rare disease Committee and also the Ministry of Health Pediatric Subspecialty Training Committee. Dr Janet has led and participated in drafting several clinical practice guidelines involving use of growth hormone, management of Type 1 diabetes and paediatric protocol for Malaysian hospitals. She has published more than 23 papers in leading journals including International Medical Journal, BMJ, Int Journal of Endocrinology, Journal of Paediatric Endocrinology and Metabolism, and Frontiers in Public Health. Dr Janet also actively involved in professional societies. She is the Deputy chairperson for Malaysian Paediatric Endocrine & Diabetes Group (MPEDG) And an Executive Council member of Malaysian Endocrine and Metabolic Society (MEMS).

Dr Lee Yee Lin is a Senior Lecturer, Consultant Paediatrician and Paediatric Endocrinologist at Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia. She obtained her MBBS degree in University of Melbourne in 2000 and MRCPCH (UK) qualification in 2010. She later completed her paediatric endocrinology training in 2018 at Universiti Kebangsaan Malaysia Medical Centre (UKMMC) and KK Women’s and Children’s Hospital in Singapore. Her research interests include Turner syndrome, growth and puberty disorders, thyroid disorders, childhood diabetes and obesity. She is a member of Malaysia Endocrine and Metabolic Society (MEMS) and Asia Pacific Paediatric Endocrine Society (APPES).

Dr Muthukkumaran obtained his Masters in Clinical Oncology from University of Malaya in 2013. He previously served at Sabah Women and Children Hospital and currently based at Hospital Kuala Lumpur’s Department of Radiotherapy and Oncology. Dr Muthukkumaran has a special interest in pulmonary oncology, genitourinary oncology, neuro oncology (including stereotactic cranial radiosurgery) and paediatric radiation. He is actively involved in both industry-sponsored and investigator-initiated clinical research. Dr Muthukkumaran is currently the President of Malaysian Oncological Society (MOS). He is a national representative to the Federation of Asian Organizations for Radiation Oncology (FARO) and International Atomic Energy Agency (IAEA).

Dr. Nalini M Selveindran is Head of Department and Consultant Paediatric Endocrinologist at the Hospital Putrajaya, a major referral hospital for endocrine disorders in Malaysia. She currently sits in the Malaysian Medical Council’s subspecialty committee for Paediatric Endocrinology. She is also involved in training and currently sits on the Malaysian Paediatric Endocrinology Subspecialty Training Committee. Besides this. she is involved in the development of the guidelines on the management of childhood obesity, congenital hypothyroidism and is currently the chair of the clinical practice guidelines on ‘Growth Hormone’. With research interests in the field of disorders of sex development and bone disorders, Dr. Nalini’s work has been published in various academic journals. She has numerous experiences presenting in conferences locally and abroad and has won various awards for her work. She is also active in various organisations and is currently in the council of the Malaysian Society for the Study of Obesity and also research head for the Malaysian Paediatric Endocrine Group.

Associate Prof Dr Noor Shafina Mohd Nor is the current Deputy Dean of Postgraduate & Professional Training at the Faculty of Medicine, Universiti Teknologi MARA (UiTM), Malaysia. She is also a consultant paediatrician and a consultant paediatric endocrinologist at Hospital Al-Sultan Abdullah UiTM. She completed her paediatric endocrinology subspecialty training in University Malaya Medical Center, Malaysia and The Children Hospital of Pittsburgh, Pennsylvania, USA in 2015. She is the current treasurer for the Malaysian Paediatric Endocrine & Diabetes Group (MPEDG). She has numerous publications in journals, books, chapters in books as well as contributed in the national clinical guidelines. She is an active researcher and her research interest is in the area of Paediatric Endocrinology particularly Diabetes Mellitus, obesity, thyroid disorders and endocrine disruptor chemicals especially Bisphenol A.

Dr. Norlela Sukor is a Professor of Medicine and Senior Consultant Endocrinologist at the Department of Medicine, Universiti Kebangsaan Malaysia Medical Center (UKMMC), Kuala Lumpur. She obtained her medical degree from the Universiti Sains Malaysia and subsequently Master of Medicine (Internal Medicine) from the Universiti Kebangsaan Malaysia. She then pursued her training and obtained her Doctor of Philosophy from The University of Queensland, Brisbane, Australia in 2009. Dr Norlela Sukor has many credentials. She has won several awards including The University of Queensland Dean’s Award 2009 for Outstanding Research Higher Degree Thesis as well as the Post Graduate Student’s Academic Excellence Award 2009 by the Malaysian Student Council of Australia and Malaysia Department of Australia. She has also been awarded with Fellow of the American College of Endocrinology (ACE), making her the first Malaysian woman to receive this recognition. She has many publications, including publications in the New England Journal of Medicine, The Lancet, Journal of Clinical Endocrinology and Metabolism, Diabetes, Obesity and Metabolism, Hypertension and Frontiers in Endocrinology.

She received her undergraduate education in University College Dublin (UCD), Dublin, Ireland. She pursued her postgraduate studies in Masters in Internal Medicine and subsequently completed her Endocrine Fellowship Training at the National University of Malaysia (UKM). She is actively involved in the teaching of both undergraduate and postgraduate programs within the faculty. She is also involved in the Endocrine services including the Weight Management Clinic, with a keen interest in bariatric surgery. She is also actively involved in research, particularly in the areas of diabetes and obesity. She has been a member of the development of various Clinical Practice Guidelines (CPG) including for Gestational Diabetes in 2019 and Management of Type 2 Diabetes Mellitus in 2021 and the upcoming CPG in Obesity.

Specialty: Paediatric Endocrinology

Dr Nurshadia Samingan is a Senior Medical Lecturer and Consultant Paediatrician and Paediatric Endocrinologist in University Malaya Medical Centre. She received her medical degree from University of Manchester in 2005 and postgraduate Master Degree of Paediatrics from University Malaya in 2012. She underwent her Paediatric Endocrine training in University Malaya Medical Centre and completed clinical fellowship in Khoo Teck Puat Children’s Hospital, National University of Singapore in 2021.

She is also an active diabetes advocator, and involved in diabetes camps and webinars. She organises annual Diabetes and Ramadhan Webinar for Type 1 diabetes patients and parents since 2021.

She is also involved in few research grants and studies involving maternal obesity dan diabetes, new medications for type 2 diabetes, obesity and hypercholesterolaemia. She was awarded Young Investigator Award in 2019 in Malaysian Endocrine and Metabolic Society Conference. Her areas of interest are growth, puberty and type 2 diabetes. 

Associate Professor Dr Suhaimi is a paediatrician specialising in Paediatric Endocrinology. He did his undergraduate in the Universiti Sains Malaysia and obtained his Medical Doctor in 1996. He completed his Master of Paediatric in 2006 and joined Universiti Sains Malaysia as a medical lecturer. Dr Suhaimi did his fellowship in Paediatric Endocrine training in UMMC, UKMMC (Kuala Lumpur) and NUH (Singapore) in 2011. He is a registered Paediatric Endocrinologist since 2012. He is a member of Asia Pacific Paediatric Endocrinology (APPES), International Society for Paediatric Adolescent Diabetes (ISPAD) and European Society Paediatric Endocrinology (ESPE). He has published many papers related to field of Paediatric Endocrinology and appointed as Principal investigators for International trial in diabetes and growth.

Dr Tan currently works as a nuclear medicine physician in Sunway Medical Centre. His practice mainly focuses on oncologic imaging using PET-CT and SPECT-CT; and systemic targeted radionuclide therapy (radioactive iodine, PRRT and PSMA therapy). He has published more than 30 peer-reviewed articles and received numerous awards. He is currently the president of Malaysian Society Nuclear Medicine and Molecular Imaging (MSNMMI); and Regional Principal of Asian Oceania School of Nuclear Medicine (AOSNM).

Doctor Alexander Tan is Consultant Endocrinologist at Sunway Medical Centre. Doctor Tan graduated from the University of Liverpool in 2001, became a member of the Royal College of Physicians (MRCPUK) in 2005 and completed his subspecialty endocrinology training in 2010. He was elected to be a fellow of the Royal College of Physicians (FRCP) of Edinburgh in 2016. He was instrumental in the formation of the Diabetes Care Unit at University of Malaya Medical Centre, a one-stop centre for all diabetes related clinical services. He has presented research in the fields of diabetes mellitus and bone health at both local and international conferences. He has also been Principal Investigator for numerous clinical trials. Doctor Tan is actively involved in speaking at various local and national level conferences.

Dr Wong Ming is currently a Consultant Endocrinologist at Sunway Medical Centre. She graduated from Royal College of Surgeons, Ireland and was a lecturer at Pusat Perubatan Universiti Kebangsaan Malaysia and adjunct clinical lecturer at Monash University Malaysia Campus She was involved in Phase 2 and 3 clinical drug trials in diabetes and hypertension. She has been invited to sit on various advisory boards on diabetes and hypertension. She is currently a member of the Malaysian Endocrine and Metabolic Society. She has published papers in endocrinology and has been invited to speak at regional and local endocrine conferences.

Dr Jeanne Wong Sze Lyn specialises in General Paediatrics and Paediatric Endocrinology. She graduated with distinction from University of Malaya in 2004, completed her paediatric specialist examinations (MRCPCH UK) in 2009, and sub-specialty fellowship in Paediatric Endocrinology (Malaysia, Sydney Australia) in 2016. She consults neonatal and childhood diseases, general paediatrics, vaccinations and endocrine conditions (age 0-18 years) which include diabetes, disorders in thyroid, growth, puberty, bone, calcium, pituitary, adrenal, hypoglycaemia, obesity and sex development. Dr Jeanne has a special interest in children’s health education. She is a contributing author of the Malaysian Paediatric Protocol; Malaysia Clinical Practice Guidelines for Management of Thyroid Disorders; Consensus Guidelines on Congenital Hypothyroidism in Malaysia and a monthly contributor on the Sunday Star newspaper’s health column published every second Sunday of the month, titled Hormones and Kids. Her journal publications include that on diabetes & thyroid.

Dr. Zanariah Hussein is a Consultant Physician and Endocrinologist. She is currently the Head of the Endocrine Unit, Hospital Putrajaya and Head of the Endocrinology Subspecialty Service of the Malaysian Ministry of Health (MOH). She chairs the MOH endocrine fellowship training program, MOH endocrine drug review committee and Endocrine Subspecialty Subcommittee of the National Specialist Register. She is active in undergraduate, postgraduate and fellowship teaching and training. She has been involved in the development of local Clinical Practice Guidelines for diabetes, obesity, thyroid disease, growth hormone therapy, dyslipidemia and CV prevention in women. Her areas of clinical and research interest are diabetes technology, adrenal and neuroendocrine tumours. She is a Past President of the Malaysian Endocrine and Metabolic Society (MEMS). She is a member of the advisory boards for the National Diabetes Institute (NADI) and Malaysian Diabetes Educator Society (MDES).